Science Talk: Fast-tracking of a COVID-19 vaccine development
– with AdaptVac and ExpreS2ion
Join us for this Science Talk with Drs. Ali Salanti, Max M Søgaard, and Louise Leth Hefting on development of a virus-like particle (VLP)-based COVID-19 vaccine and what the companies behind it, AdaptVac and ExpreS2ion Biotechnologies, have done to fast-track their developmental pipeline.
- Max M Søgaard, PhD, Vice President at ExpreS2ion Biotechnologies.
- Ali Salanti, PhD, Professor of Translational Microbiologi; Founder & Board Member at AdaptVac
- Louise Leth Hefting, PhD, Field Application Scientist at ChemoMetec A/S
- Janny Marie L Peterslund, PhD, Scientific Affairs Manager at ChemoMetec A/S
Duration: 36 minutes